Cargando…
Reemergence of Intravenous Drug Use as Risk Factor for Candidemia, Massachusetts, USA
The epidemic of illicit intravenous drug use (IVDU) in the United States has been accompanied by a surge in drug overdose deaths and infectious sequelae. Candida albicans infections were associated with injection of contaminated impure brown heroin in the 1970s–1990s; however, candidiasis accompanyi...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5875264/ https://www.ncbi.nlm.nih.gov/pubmed/29553923 http://dx.doi.org/10.3201/eid2404.171807 |
_version_ | 1783310333450911744 |
---|---|
author | Poowanawittayakom, Nongnooch Dutta, Anamika Stock, Shannon Touray, Sunkaru Ellison, Richard T. Levitz, Stuart M. |
author_facet | Poowanawittayakom, Nongnooch Dutta, Anamika Stock, Shannon Touray, Sunkaru Ellison, Richard T. Levitz, Stuart M. |
author_sort | Poowanawittayakom, Nongnooch |
collection | PubMed |
description | The epidemic of illicit intravenous drug use (IVDU) in the United States has been accompanied by a surge in drug overdose deaths and infectious sequelae. Candida albicans infections were associated with injection of contaminated impure brown heroin in the 1970s–1990s; however, candidiasis accompanying IVDU became considerably rarer as the purity of the heroin supply increased. We reviewed cases of candidemia occurring over a recent 7-year period in persons >14 years of age at a tertiary care hospital in central Massachusetts. Of the 198 patients with candidemia, 24 cases occurred in patients with a history of IVDU. Compared with non-IVDU patients, those with a history of IVDU were more likely to have non-albicans Candida, be co-infected with hepatitis C, and have end-organ involvement, including endocarditis and osteomyelitis. Thus, IVDU appears to be reemerging as a risk factor for invasive candidiasis. |
format | Online Article Text |
id | pubmed-5875264 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Centers for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-58752642018-04-06 Reemergence of Intravenous Drug Use as Risk Factor for Candidemia, Massachusetts, USA Poowanawittayakom, Nongnooch Dutta, Anamika Stock, Shannon Touray, Sunkaru Ellison, Richard T. Levitz, Stuart M. Emerg Infect Dis Synopsis The epidemic of illicit intravenous drug use (IVDU) in the United States has been accompanied by a surge in drug overdose deaths and infectious sequelae. Candida albicans infections were associated with injection of contaminated impure brown heroin in the 1970s–1990s; however, candidiasis accompanying IVDU became considerably rarer as the purity of the heroin supply increased. We reviewed cases of candidemia occurring over a recent 7-year period in persons >14 years of age at a tertiary care hospital in central Massachusetts. Of the 198 patients with candidemia, 24 cases occurred in patients with a history of IVDU. Compared with non-IVDU patients, those with a history of IVDU were more likely to have non-albicans Candida, be co-infected with hepatitis C, and have end-organ involvement, including endocarditis and osteomyelitis. Thus, IVDU appears to be reemerging as a risk factor for invasive candidiasis. Centers for Disease Control and Prevention 2018-04 /pmc/articles/PMC5875264/ /pubmed/29553923 http://dx.doi.org/10.3201/eid2404.171807 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited. |
spellingShingle | Synopsis Poowanawittayakom, Nongnooch Dutta, Anamika Stock, Shannon Touray, Sunkaru Ellison, Richard T. Levitz, Stuart M. Reemergence of Intravenous Drug Use as Risk Factor for Candidemia, Massachusetts, USA |
title | Reemergence of Intravenous Drug Use as Risk Factor for Candidemia, Massachusetts, USA |
title_full | Reemergence of Intravenous Drug Use as Risk Factor for Candidemia, Massachusetts, USA |
title_fullStr | Reemergence of Intravenous Drug Use as Risk Factor for Candidemia, Massachusetts, USA |
title_full_unstemmed | Reemergence of Intravenous Drug Use as Risk Factor for Candidemia, Massachusetts, USA |
title_short | Reemergence of Intravenous Drug Use as Risk Factor for Candidemia, Massachusetts, USA |
title_sort | reemergence of intravenous drug use as risk factor for candidemia, massachusetts, usa |
topic | Synopsis |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5875264/ https://www.ncbi.nlm.nih.gov/pubmed/29553923 http://dx.doi.org/10.3201/eid2404.171807 |
work_keys_str_mv | AT poowanawittayakomnongnooch reemergenceofintravenousdruguseasriskfactorforcandidemiamassachusettsusa AT duttaanamika reemergenceofintravenousdruguseasriskfactorforcandidemiamassachusettsusa AT stockshannon reemergenceofintravenousdruguseasriskfactorforcandidemiamassachusettsusa AT touraysunkaru reemergenceofintravenousdruguseasriskfactorforcandidemiamassachusettsusa AT ellisonrichardt reemergenceofintravenousdruguseasriskfactorforcandidemiamassachusettsusa AT levitzstuartm reemergenceofintravenousdruguseasriskfactorforcandidemiamassachusettsusa |